Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans

被引:46
作者
Burd, Nicholas A. [1 ]
Dickinson, Jared M. [1 ]
LeMoine, Jennifer K. [1 ]
Carroll, Chad C. [1 ]
Sullivan, Bridget E. [1 ]
Haus, Jacob M. [1 ]
Jemiolo, Bozena [1 ]
Trappe, Scott W. [1 ]
Hughes, Gordon M. [1 ]
Sanders, Charles E., Jr. [1 ]
Trappe, Todd A. [1 ]
机构
[1] Ball State Univ, Human Performance Lab, Muncie, IN 47306 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2010年 / 298卷 / 02期
关键词
celecoxib; H-2(5)]phenylalanine; resistance exercise; HUMAN SKELETAL-MUSCLE; RESISTANCE EXERCISE; GENE-EXPRESSION; COX-2; PATHWAY; TIME-COURSE; CLINICAL PHARMACOKINETICS; ARACHIDONIC-ACID; MESSENGER-RNA; HUMAN SOLEUS; ACETAMINOPHEN;
D O I
10.1152/ajpendo.00423.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Burd NA, Dickinson JM, LeMoine JK, Carroll CC, Sullivan BE, Haus JM, Jemiolo B, Trappe SW, Hughes GM, Sanders CE Jr., Trappe TA. Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans. Am J Physiol Endocrinol Metab 298: E354-E361, 2010. First published November 24, 2009; doi:10.1152/ajpendo.00423.2009.-Nonselective blockade of the cyclooxygenase (COX) enzymes in skeletal muscle eliminates the normal increase in muscle protein synthesis following resistance exercise. The current study tested the hypothesis that this COX-mediated increase in postexercise muscle protein synthesis is regulated specifically by the COX-2 isoform. Sixteen males (23 +/- 1 yr) were randomly assigned to one of two groups that received three doses of either a selective COX-2 inhibitor (celecoxib; 200 mg/dose, 600 mg total) or a placebo in double-blind fashion during the 24 h following a single bout of knee extensor resistance exercise. At rest and 24 h postexercise, skeletal muscle protein fractional synthesis rate (FSR) was measured using a primed constant infusion of [H-2(5)]phenylalanine coupled with muscle biopsies of the vastus lateralis, and measurements were made of mRNA and protein expression of COX-1 and COX-2. Mixed muscle protein FSR in response to exercise (P < 0.05) was not suppressed by the COX-2 inhibitor (0.056 +/- 0.004 to 0.108 +/- 0.014%/h) compared with placebo (0.074 +/- 0.004 to 0.091 +/- 0.005%/h), nor was there any difference (P > 0.05) between the placebo and COX-2 inhibitor postexercise when controlling for resting FSR. The COX-2 inhibitor did not influence COX-1 mRNA, COX-1 protein, or COX-2 protein levels, whereas it did increase (P < 0.05) COX-2 mRNA (3.0 +/- 0.9-fold) compared with placebo (1.3 +/- 0.3-fold). It appears that the elimination of the postexercise muscle protein synthesis response by nonselective COX inhibitors is not solely due to COX-2 isoform blockade. Furthermore, the current data suggest that the COX-1 enzyme is likely the main isoform responsible for the COX-mediated increase in muscle protein synthesis following resistance exercise in humans.
引用
收藏
页码:E354 / E361
页数:8
相关论文
共 68 条
  • [1] BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1
  • [2] The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms
    Bondesen, BA
    Mills, ST
    Pavlath, GK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 290 (06): : C1651 - C1659
  • [3] The COX-2 pathway is essential during early stages of skeletal muscle regeneration
    Bondesen, BA
    Mills, ST
    Kegley, KM
    Pavlath, GK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (02): : C475 - C483
  • [4] THE DETERMINATION OF LOW D(5)-PHENYLALANINE ENRICHMENT (0.002-0.09 ATOM PERCENT EXCESS), AFTER CONVERSION TO PHENYLETHYLAMINE, IN RELATION TO PROTEIN-TURNOVER STUDIES BY GAS-CHROMATOGRAPHY ELECTRON IONIZATION MASS-SPECTROMETRY
    CALDER, AG
    ANDERSON, SE
    GRANT, I
    MCNURLAN, MA
    GARLICK, PJ
    [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 1992, 6 (07) : 421 - 424
  • [5] Carrithers J A, 2002, J Gravit Physiol, V9, pP155
  • [6] Human soleus and vastus lateralis muscle protein metabolism with an amino acid infusion
    Carroll, CC
    Fluckey, JD
    Williams, RH
    Sullivan, DH
    Trappe, TA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 288 (03): : E479 - E485
  • [7] Personal digital video: A method to monitor drug regimen adherence during human clinical investigations
    Carroll, Chad C.
    Trappe, Todd A.
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (12): : 1125 - 1127
  • [8] Human cyclooxygenase-1b is not the elusive target of acetaminophen
    Censarek, Petra
    Freidel, Kerstin
    Hohfeld, Thomas
    Schroer, Karsten
    Weber, Artur-Aron
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 551 (1-3) : 50 - 53
  • [9] COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
    Chandrasekharan, NV
    Dai, H
    Roos, KLT
    Evanson, NK
    Tomsik, J
    Elton, TS
    Simmons, DL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) : 13926 - 13931
  • [10] The cyclooxygenases
    Chandrasekharan, NV
    Simmons, DL
    [J]. GENOME BIOLOGY, 2004, 5 (09)